OCEANIC-AF is one trial which evaluates asundexian versus apixaban in patients with atrial fibrillation at risk for stroke within the overall OCEANIC phase III program
Extraintestinal pathogenic E. coli (ExPEC) has been identified as the leading bacterial cause of sepsis
Dr. Lal Path Labs has reported total income of Rs. 619.4 crores during the period ended September 30, 2023
Zydus will pay an upfront consideration of GBP 68 million and yearly earn-outs until 2026
Revenue in the three months ended on Oct. 1 also slipped by 42% to US$ 13.23 billion
CB03 is a candidate drug for the treatment of ALS and other central nerve system (CNS) diseases
The composition of ORAAL is protected by a granted patent in India until November 2033
Tele-MANAS has counseled more than 3,50,000 people till date and currently provides counseling to 2000 people through 44 Tele Manas Cells
Approval is for use in myelofibrosis patients with anaemia regardless of prior myelofibrosis therapy
The non-enzymatic electrochemical sensing strip can simultaneously detect the direct and total bilirubin in a single drop of blood, and provide the concentrations within a minute
Subscribe To Our Newsletter & Stay Updated
